Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

Pharmacophore

After the Quantum Advantage Claim: Which Drug-Discovery Problems Are Actually Ready for Quantum Computation?

Lucas Meyer, Anna Schmid, Stefan Braun, Laura Keller

Published Jan 1, 2026• 0 citations
Publisher

Abstract

Quantum computation is increasingly presented as a potential response to difficult molecular-simulation, optimization, and machine-learning problems in drug discovery. However, the existence of computationally demanding pharmaceutical tasks does not establish that quantum methods can solve them more accurately, efficiently, or usefully than contemporary classical approaches. This horizon-scanning review evaluates which problem classes currently justify bounded quantum research programs and which

DOI
10.51847/ytvqqiwlce

Related papers

Quantum–Classical Drug Discovery after the Advantage Claim: Matching Computational Methods to Problems They Can Credibly Solve

David Thompson, Sarah Mitchell, Rachel Adams +1 more

Quantum computing has become increasingly visible in pharmaceutical research, yet the evidentiary meaning of an “advantage” claim remains unsettled. Drug discovery contains heterogeneous scientific decisions, data structures, computational abstractions, validation standards, and translational consequences. Consequently, improvement in circuit execution, molecular-energy estimation, sampling, classification, or candidate generation cannot by itself establish pharmaceutical usefulness. This Origin

Pharmacophore•Jan 1, 2025•0 citations

Evaluating Quantum And Classical Computing Approaches In Modern Drug Discovery

R. Saniya Paul, Livistone S P, Dr. S. Sheeja

Drug discovery is inherently complex and expensive with many requisites in terms of precision with respect to interactions\\\' molecular modelling, biological activity prediction and chemical compounds optimisation. Classical computing methods have contributed substantially to the progress of computational drug discovery via molecular simulations, machine learning models and high-throughput virtual screening. However, challenges emerge from the exponentiality of molecular configuration space and the low efficiency of classical algorithms. Quantum computing as a new computing paradigm that offers a novel approach to computation based on various phenomena such as superposition and entanglement and therefore offers a way to overcome the previous limitations. This work presents a comparison of classical and quantum computing approaches in drug discovery with emphasis on their strengths and weaknesses, current progress and future prospects in different aspects of pharmaceutical research.

•Jan 1, 2026•0 citations

Potential of quantum computing for drug discovery

Yudong Cao, Jonathan Romero, Alán Aspuru‐Guzik

Quantum computing has rapidly advanced in recent years due to substantial development in both hardware and algorithms. These advances are carrying quantum computers closer to their impending commercial utility. Drug discovery is a promising area of application that will find a number of uses for these new machines. As a prominent example, quantum simulation will enable faster and more accurate characterizations of molecular systems than existing quantum chemistry methods. Furthermore, algorithmic developments in quantum machine learning offer interesting alternatives to classical machine learning techniques, which may also be useful for the biochemical efforts involved in early phases of drug discovery. Meanwhile, quantum hardware is scaling up rapidly into a regime where an exact simulation is difficult even using the world’s largest supercomputers. We review how these recent advances can shift the paradigm with which one thinks about drug discovery, focusing on both the promises and caveats associated with each development. In particular, we highlight how hybrid quantum-classical approaches to quantum simulation and quantum machine learning could yield substantial progress using noisy-intermediate scale quantum devices, whereas fault-tolerant, error-corrected quantum computers are still in their development phase.

IBM Journal of Research and Development•Nov 1, 2018•395 citations

Quantum Computing in Drug Discovery: Revolutionizing Pharmaceutical Research

Anandhavalli Muniasamy

The integration of quantum computing in drug discovery has the potential to revolutionize pharmaceutical research by significantly enhancing molecular simulations, drug screening, and optimization processes. Traditional computational methods often struggle with the complexity of molecular interactions, leading to high costs and extended timelines in drug development. Quantum computing, with its ability to process complex calculations exponentially faster than classical computers, offers innovative solutions to these challenges. This chapter explores the fundamentals of quantum computing, its application in pharmaceutical research, and real-world case studies from leading organizations. It also discusses existing challenges, potential solutions, and future directions for adopting quantum computing in drug discovery. By addressing key technical, ethical, and regulatory aspects, this chapter provides a comprehensive analysis of how quantum technologies can accelerate and optimize the drug discovery pipeline.

IGI Global eBooks•Jul 11, 2025•8 citations

Quantum computing in drug discovery

Ruby Srivastava

Quantum computers are recently being developed in wide varieties, but the computational results from quantum computing have been largely confined to constructing artificial assignments. The applications of quantum computers to real-world problems are still an active area of research. However, challenges arise when the limits of scale and complexity in biological problems are pushed, which has affected drug discovery. The fast-evolving quantum computing technology has transformed the computational capabilities in drug research by searching for solutions for complicated and tedious calculations. Quantum computing (QC) is exponentially more efficient in drug discovery, treatment, and therapeutics, generating profitable business for the pharmaceutical industry. In principle, it can be stated that quantum computing can solve complex problems exponentially faster than classical computing. Here it is needed to mention that QC will not be able to take on every task that classical computers perform—at least not now. It may be classical and quantum-coupled computational technologies combined with machine learning (ML) and artificial intelligence (AI) will solve each task in the future. This review is an overview of quantum computing, which may soon revolutionize the pharmaceutical industry in drug discovery.

Information System and Smart City•Dec 11, 2023•4 citations

Quantum computing in drug discovery

Ruby Srivastava

Quantum computers are recently being developed in wide varieties, but the computational results from quantum computing have been largely confined to constructing artificial assignments. The applications of quantum computers to real-world problems are still an active area of research. However, challenges arise when the limits of scale and complexity in biological problems are pushed, which has affected drug discovery. The fast-evolving quantum computing technology has transformed the computational capabilities in drug research by searching for solutions for complicated and tedious calculations. Quantum computing (QC) is exponentially more efficient in drug discovery, treatment, and therapeutics, generating profitable business for the pharmaceutical industry. In principle, it can be stated that quantum computing can solve complex problems exponentially faster than classical computing. Here it is needed to mention that QC will not be able to take on every task that classical computers perform—at least not now. It may be classical and quantum-coupled computational technologies combined with machine learning (ML) and artificial intelligence (AI) will solve each task in the future. This review is an overview of quantum computing, which may soon revolutionize the pharmaceutical industry in drug discovery.

Information System and Smart City•Dec 11, 2023•18 citations
Quantum computation is increasingly presented as a potential response to difficult molecular-simulation, optimization, and machine-learning problems in drug discovery. However, the existence of computationally demanding pharmaceutical tasks does not establish that quantum methods can solve them more accurately, efficiently, or usefully than contemporary classical approaches. This horizon-scanning review evaluates which problem classes currently justify bounded quantum research programs and which
Quantum computing has become increasingly visible in pharmaceutical research, yet the evidentiary meaning of an “advantage” claim remains unsettled. Drug discovery contains heterogeneous scientific decisions, data structures, computational abstractions, validation standards, and translational consequences. Consequently, improvement in circuit execution, molecular-energy estimation, sampling, classification, or candidate generation cannot by itself establish pharmaceutical usefulness. This Origin
Drug discovery is inherently complex and expensive with many requisites in terms of precision with respect to interactions\\\' molecular modelling, biological activity prediction and chemical compounds optimisation. Classical computing methods have contributed substantially to the progress of computational drug discovery via molecular simulations, machine learning models and high-throughput virtual screening. However, challenges emerge from the exponentiality of molecular configuration space and the low efficiency of classical algorithms. Quantum computing as a new computing paradigm that offers a novel approach to computation based on various phenomena such as superposition and entanglement and therefore offers a way to overcome the previous limitations. This work presents a comparison of classical and quantum computing approaches in drug discovery with emphasis on their strengths and weaknesses, current progress and future prospects in different aspects of pharmaceutical research.
Quantum computing has rapidly advanced in recent years due to substantial development in both hardware and algorithms. These advances are carrying quantum computers closer to their impending commercial utility. Drug discovery is a promising area of application that will find a number of uses for these new machines. As a prominent example, quantum simulation will enable faster and more accurate characterizations of molecular systems than existing quantum chemistry methods. Furthermore, algorithmic developments in quantum machine learning offer interesting alternatives to classical machine learning techniques, which may also be useful for the biochemical efforts involved in early phases of drug discovery. Meanwhile, quantum hardware is scaling up rapidly into a regime where an exact simulation is difficult even using the world’s largest supercomputers. We review how these recent advances can shift the paradigm with which one thinks about drug discovery, focusing on both the promises and caveats associated with each development. In particular, we highlight how hybrid quantum-classical approaches to quantum simulation and quantum machine learning could yield substantial progress using noisy-intermediate scale quantum devices, whereas fault-tolerant, error-corrected quantum computers are still in their development phase.
The integration of quantum computing in drug discovery has the potential to revolutionize pharmaceutical research by significantly enhancing molecular simulations, drug screening, and optimization processes. Traditional computational methods often struggle with the complexity of molecular interactions, leading to high costs and extended timelines in drug development. Quantum computing, with its ability to process complex calculations exponentially faster than classical computers, offers innovative solutions to these challenges. This chapter explores the fundamentals of quantum computing, its application in pharmaceutical research, and real-world case studies from leading organizations. It also discusses existing challenges, potential solutions, and future directions for adopting quantum computing in drug discovery. By addressing key technical, ethical, and regulatory aspects, this chapter provides a comprehensive analysis of how quantum technologies can accelerate and optimize the drug discovery pipeline.
Quantum computers are recently being developed in wide varieties, but the computational results from quantum computing have been largely confined to constructing artificial assignments. The applications of quantum computers to real-world problems are still an active area of research. However, challenges arise when the limits of scale and complexity in biological problems are pushed, which has affected drug discovery. The fast-evolving quantum computing technology has transformed the computational capabilities in drug research by searching for solutions for complicated and tedious calculations. Quantum computing (QC) is exponentially more efficient in drug discovery, treatment, and therapeutics, generating profitable business for the pharmaceutical industry. In principle, it can be stated that quantum computing can solve complex problems exponentially faster than classical computing. Here it is needed to mention that QC will not be able to take on every task that classical computers perform—at least not now. It may be classical and quantum-coupled computational technologies combined with machine learning (ML) and artificial intelligence (AI) will solve each task in the future. This review is an overview of quantum computing, which may soon revolutionize the pharmaceutical industry in drug discovery.
Quantum computers are recently being developed in wide varieties, but the computational results from quantum computing have been largely confined to constructing artificial assignments. The applications of quantum computers to real-world problems are still an active area of research. However, challenges arise when the limits of scale and complexity in biological problems are pushed, which has affected drug discovery. The fast-evolving quantum computing technology has transformed the computational capabilities in drug research by searching for solutions for complicated and tedious calculations. Quantum computing (QC) is exponentially more efficient in drug discovery, treatment, and therapeutics, generating profitable business for the pharmaceutical industry. In principle, it can be stated that quantum computing can solve complex problems exponentially faster than classical computing. Here it is needed to mention that QC will not be able to take on every task that classical computers perform—at least not now. It may be classical and quantum-coupled computational technologies combined with machine learning (ML) and artificial intelligence (AI) will solve each task in the future. This review is an overview of quantum computing, which may soon revolutionize the pharmaceutical industry in drug discovery.